Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy.

Thyroid

Division of Endocrinology, Diabetes, Metabolism, Nutrition and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

Published: December 2003

It is generally considered that thyroid dermopathy and acropachy almost always occur with Graves' ophthalmopathy and that these two extrathyroidal manifestations are indicators of severe autoimmune disease and hence of more severe ophthalmopathy. However, documentation of these anecdotal impressions is needed. We assessed the presence of optic neuropathy and frequency of orbital decompression in 2 referral cohorts: 40 patients with acropachy and dermopathy (acropachy group) and 138 patients with Graves' dermopathy and no acropachy (dermopathy group). We compared those cohorts with a cohort of 114 patients who had ophthalmopathy without dermopathy and acropachy (control group). We considered optic neuropathy and the need for orbital decompression to be indicators of severe Graves' ophthalmopathy. The frequency of orbital decompression was significantly higher in the dermopathy group than in the control group (odds ratio, 3.55) and even higher in the acropachy group (odds ratios: 20.68 for acropachy group compared with control group; 5.83 for acropachy group compared with dermopathy group). The same trend occurred with optic neuropathy but was not statistically significant (alpha = 0.05; p = 0.07). Five patients were exceptions: they had definite Graves' dermopathy without clinically obvious ophthalmopathy. In conclusion, dermopathy and acropachy appear to be markers of severe ophthalmopathy. Occasionally, however, Graves' dermopathy occurs without clinical ophthalmopathy.

Download full-text PDF

Source
http://dx.doi.org/10.1089/10507250360731541DOI Listing

Publication Analysis

Top Keywords

dermopathy acropachy
24
graves' dermopathy
16
acropachy group
16
graves' ophthalmopathy
12
optic neuropathy
12
orbital decompression
12
dermopathy group
12
group compared
12
control group
12
acropachy
10

Similar Publications

Hypertrophic osteoarthropathy (HOA: MIM 167100)) is classified into primary and secondary types. Primary HOA, also known as pachydermoperiostosis (PDP), is a rare genetic condition with distinct clinical features including digital clubbing, skin thickening, and periostosis. Secondary HOA often occurs as a paraneoplastic syndrome or is associated with systemic diseases.

View Article and Find Full Text PDF

Targeting Metabolomics in Primary Hypertrophic Osteoarthropathy: Uncovering Novel Insights into Disease Pathogenesis.

J Clin Endocrinol Metab

November 2024

Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory for Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing 100730, China.

Context: Primary hypertrophic osteoarthropathy (PHO) is a rare genetic disorder characterized by skeletal and skin abnormalities. Genetic defects in prostaglandin E2 (PGE2) metabolism are known to cause PHO. However, the global impact and clinical significance of eicosanoids and oxylipins beyond PGE2 remain to be elucidated.

View Article and Find Full Text PDF

A 40-year-old African-American man was referred to our dermatology clinic for management of his long-standing thyroid dermopathy. The patient was diagnosed with hyperthyroidism at the age of 20, and was treated with radioactive iodine I-131 but subsequently lost to follow-up. He had not consulted physicians again until the age of 30.

View Article and Find Full Text PDF

Graves' disease thyroid dermopathy: a case report.

J Med Case Rep

April 2024

Department of Pediatrics, King Faisal Specialist Hospital and Research Centre, Al Takhassousi & 12713, 11211, Riyadh, Saudi Arabia.

Article Synopsis
  • Graves' disease is an autoimmune disorder leading to thyroid gland enlargement and overactivity, with various symptoms affecting multiple organ systems, including thyroid-related skin conditions.
  • The case presented involves an 11-year-old boy from Saudi Arabia with symptoms like goiter and bulging eyes, alongside unusual swelling and nodules on his body that resembled a lymphatic issue.
  • Treatment options including steroid injections and total thyroid removal improved the patient's condition, highlighting the rare manifestations of thyroid dermopathy in this case.
View Article and Find Full Text PDF

Comprehensive Treatment of a Rare Case of Complete Primary Pachydermoperiostosis with Large Facial Keloid Scars: A Case Report and Literature Review.

Case Rep Dermatol

March 2024

Department of Dermatology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.

Article Synopsis
  • Pachydermoperiostosis (PDP) is a rare genetic disorder characterized by skin thickening, new bone growth, and sometimes keloid scar formation, which may involve an excess of fibroblasts and irregular connective tissue.* -
  • A case study of a 25-year-old man with PDP included symptoms like facial skin folding, joint pain, and clubbing of fingers and toes, which led to treatments including skin dermabrasion and various injectable therapies to manage his keloid scars.* -
  • Despite the unclear cause of PDP, most patients stabilize over time, and tailored treatment plans involving multiple therapies can effectively address the challenges posed by keloids and improve patient outcomes.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!